Seer, Inc.
NASDAQ:SEERBiotechnology
+$0.01 today
- Market cap
- $77.30M
- Beta
- 1.59
- P/E (TTM)
- -1.4
- EPS (TTM)
- -$1.26
Volume 0.25M
Average 0.32M
Cash Flow
Check whether earnings turn into cash.
Operating Cash Flow
-$44.45M
FY 2025 · Annual
Investing Cash Flow
$61.55M
FY 2025 · Annual
-6.5% YoYFinancing Cash Flow
-$10.57M
FY 2025 · Annual
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | (71.17M) | (92.97M) | (86.28M) | (86.6M) | (73.6M) |
| Depreciation & Amortization | 2.56M | 3.94M | 5.58M | 6.18M | 7.25M |
| Deferred Income Tax | 1.2M | 0 | 0 | 0 | 0 |
| Stock-Based Compensation | 25.93M | 33.67M | 34.42M | 28.21M | 15.41M |
| Change in Working Capital | (5.87M) | (7.09M) | (2.72M) | (144K) | (579K) |
| Accounts Receivables | (2.5M) | (2.87M) | 302K | 487K | 277K |
| Inventory | (3.59M) | (1.59M) | (1.95M) | (2.67M) | (2.9M) |
| Accounts Payables | 1.6M | (1.55M) | (987K) | 3.36M | 1.06M |
| Other Working Capital | (1.38M) | (1.07M) | (91K) | (1.32M) | 983K |
| Other Non-Cash Items | 1.01M | 1.66M | (10.07M) | 6.25M | 7.07M |
| Operating Cash Flow | (46.35M) | (60.78M) | (59.07M) | (46.11M) | (44.45M) |
| Capital Expenditures | (6.92M) | (10.27M) | (7.31M) | (3.58M) | (1.8M) |
| Acquisitions (Net) | 163.96M | 0 | 0 | 0 | 0 |
| Purchases of Investments | (279.96M) | (366.27M) | (403.09M) | (272.93M) | (173.17M) |
| Sales of Investments | 116M | 253.65M | 448.31M | 342.03M | 237.81M |
| Other Investing Activities | (163.96M) | 170K | 0 | 343K | (1.3M) |
| Investing Cash Flow | (170.88M) | (122.72M) | 37.9M | 65.86M | 61.55M |
| Debt Repayment | 0 | 0 | 0 | 0 | 0 |
| Common Stock Issued | 102.96M | 0 | 0 | 0 | 458K |
| Common Stock Repurchased | (35K) | (20K) | (13K) | (11.82M) | (10.2M) |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 13.71M | 3.91M | 465K | 321K | (827K) |
| Financing Cash Flow | 116.63M | 3.89M | 452K | (11.5M) | (10.57M) |
| Effect of Forex Changes | 0 | 0 | 0 | 0 | 0 |
| Net Change in Cash | (100.59M) | (179.61M) | (20.71M) | 8.25M | 6.53M |
| Free Cash Flow | (53.27M) | (71.05M) | (66.37M) | (49.69M) | (46.25M) |
Free Cash Flow
Net Income to FCF bridge
FY2025
Analysis
FY2025 free cash flow is -$46.2M. FCF conversion is 62.8% of net income. Operating cash flow was -$44.4M, with capex of -$1.8M. The largest bridge item is Stock-Based Comp at $15.4M.
Competitors
Peer companies in the same sector
Kymera Therapeutics, Inc.
NASDAQ:KYMR
Market cap
$10.89B
Pharvaris N.V.
NASDAQ:PHVS
Market cap
$2.34B
Nurix Therapeutics, Inc.
NASDAQ:NRIX
Market cap
$1.69B
Mineralys Therapeutics, Inc.
NASDAQ:MLYS
Market cap
$1.36B
ORIC Pharmaceuticals, Inc.
NASDAQ:ORIC
Market cap
$814.71M
Monte Rosa Therapeutics, Inc.
NASDAQ:GLUE
Market cap
$800.67M
Cullinan Therapeutics, Inc.
NASDAQ:CGEM
Market cap
$667.39M
Sana Biotechnology, Inc.
NASDAQ:SANA
Market cap
$605.26M
Shattuck Labs, Inc.
NASDAQ:STTK
Market cap
$473.57M
C4 Therapeutics, Inc.
NASDAQ:CCCC
Market cap
$362.43M
Lyell Immunopharma, Inc.
NASDAQ:LYEL
Market cap
$351.57M
PepGen Inc.
NASDAQ:PEPG
Market cap
$301.98M
Quantum-Si incorporated
NASDAQ:QSI
Market cap
$229.78M
AN2 Therapeutics, Inc.
NASDAQ:ANTX
Market cap
$172.64M
Foghorn Therapeutics Inc.
NASDAQ:FHTX
Market cap
$124.12M
Molecular Partners AG
NASDAQ:MOLN
Market cap
$112.71M
Nkarta, Inc.
NASDAQ:NKTX
Market cap
$85.23M
MediciNova, Inc.
NASDAQ:MNOV
Market cap
$68.66M
Recent Filings
Recent regulatory filings
| Filing | Description | Date | |
|---|---|---|---|
| 8-K | Current report | Nov 10, 2026 | |
| 10-Q | Quarterly report | Nov 10, 2026 | |
| 4 | Statement of changes in beneficial ownership | Nov 4, 2026 | |
| SC 13D | SC 13D filing | Nov 2, 2026 | |
| 8-K | Current report | Oct 29, 2026 |
Does SEER generate free cash flow?
Seer, Inc. (SEER) generated -$46.24M of free cash flow in fiscal 2025.
How much operating cash flow does SEER produce?
Operating cash flow was -$44.45M, before capital expenditures of $1.80M.
Continue the stock analysis
Jump to another research area for this company.